At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multicenter Pilot Study to Compare the Efficacy of a Combination of Vaginal Capsules With Acid Boric, L.Gasseri and L.Rhamnosus Versus the Reference Medication in Patients With Vaginal Candidiasis or Bacterial Vaginosis
In Brief
A Phase 4 clinical trial evaluating Boric acid and probiotics, Antibiotic (Clindamycin), and 1 other intervention for Candidiasis and Vaginosis, Bacterial. Completed, enrolled 48 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether a formula of boric acid and probiotics for vaginal application is effective in the treatment of symptomatic episodes of vulvovaginitis in comparison to pharmacological reference controls (depending on the suspected diagnosis).
Study Details
Timeline
Interventions
Vaginal capsules administered once a day during 7 days.
Vaginal capsules containing a reference antibiotic (when bacterial vaginosis is suspected) administered once a day during 3 days.
Vaginal capsules containing a reference anti-fungal (when candidiasis is suspected) administered once a day during 6 days.